• linkedin
  • Increase Font
  • Sharebar

    September 2014 New Urology Products: iPad app works with genomic test to plot post-prostatectomy care

    iPad app works with genomic test to plot post-prostatectomy care

    Decipher Portal Professional iPad app

    Austin, TX—The Decipher Portal Professional iPad app is designed to educate physicians on the optimal post-prostatectomy course of action for individual prostate cancer patients. Developed by Visible Health and launched by GenomeDx Biosciences, the app works in tandem with GenomeDx’s Decipher genomic test that uses the expression of 22 RNA biomarkers to calculate the probability of metastasis within 5 years of prostatectomy. A recent study showed 31% of treatment recommendations changed with knowledge of genomic classifiers.

    For more information, visit www.visiblehealth.com.

    Generic version of testosterone gel launched under new partnership

    Chesterbrook, PA—Auxilium Pharmaceuticals, Inc. has partnered with Prasco, LLC to introduce an authorized generic version of Testim (testosterone gel). Testim and its authorized generic version are testosterone gels approved by the FDA for the treatment of adult males with low or no testosterone. Auxilium will maintain responsibility for the manufacture of Testim and the generic gel, as well as for the distribution of branded Testim. Prasco has begun shipping the product.

    For more information, visit www.auxilium.com.


    Next: Exercise program strengthens male pelvic muscles

    More urology products

    July 2014 New Urology Products: App combines patient health data, secure Web access for physicians

    June 2014 New Urology Products: Ureteral access sheath designed to optimize day-to-day procedures

    May 2014 New Urology Products: Laser platform performs enucleation, ureteroscopy, PCNL

    Benjamin P. Saylor
    Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available